中文产业新闻精选评分79Chinese source
FDA批准武田Orzeyful用于成人1型发作性睡病，为全球首款靶向食欲素缺失病因药物
首创！武田新药上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
首创！武田新药上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.